CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 45.49% | -8.49% | -22.47% | |
| 2 | LENZ | Lenz Therapeutics INC | Stock-Other | 28.14% | -10.95% | — | |
| 3 | JBIO | Jade Biosciences INC | Stock-Other | 15.59% | -0.43% | — | |
| 4 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 5.17% | -0.16% | — | |
| 5 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 4.11% | +0.90% | — | |
| 6 | SKYE | Skye Bioscience INC | Stock-Other | 1.00% | -0.13% | — | |
| 7 | OVASUSD | Tempest Therapeutics INC | Stock-Other | 0.51% | -0.20% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | +25.8% | -22.47% | Trim |
| 2 | JBIO | Jade Biosciences INC | +9.4% | — | Unchanged |
| 3 | CTNM | Contineum Therapeutics Inc-a | +1.1% | — | Unchanged |
| 4 | CRSP | CRISPR Therapeutics AG | +0.6% | — | Unchanged |
| 5 | OVASUSD | Tempest Therapeutics INC | -0.8% | — | Unchanged |
| 6 | SKYE | Skye Bioscience INC | -2.7% | — | Unchanged |
| 7 | LENZ | Lenz Therapeutics INC | -30.1% | — | Unchanged |
| 8 | RPTX | Repare Therapeutics INC | — | EXIT | Sold out |
| 9 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | Sold out |